OSGIN1 and hepatocellular carcinoma: Through immunohistochemistry, OSGIN-1 was found to be at reduced or even undetectable levels in 74 of 92 hepatocellular carcinoma samples included in the study, matching the prior work with mammary gland carcinoma [60].